LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Profit Margin

The latest profit margin for LSBPW is -66.9% as of March 2024. That compares with 12.79% in the prior-year period — down 623.2% year over year. That is below the sector sector average of 19.74%. Investors often review this figure alongside LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LSBPW's profit margin moved from 12.79% to -66.9% — a 623.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s valuation or profitability profile.

Against its sector companies, LSBPW currently prints -66.9% for profit margin, while the sector average sits near 19.74%. That is roughly 438.9% below the sector mean. Large gaps often invite a closer look at LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s growth, margins, and balance sheet.

Profit Margin shows how effectively LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) converts resources into returns. At -66.9%, LSBPW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 12.79% in the prior-year period — down 623.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LSBPW's profit margin (-66.9%), review year-over-year change from 12.79%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.